Altos Labs, backed by $3 billion from Jeff Bezos and others, has snagged a small Peninsula company focused on one approach to ...

Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) announced Monday that it has secured the winning bid in the bankruptcy auction ...

Regeneron acquires bankrupt 23andMe for $256M, taking over its DNA database and services while pledging to uphold privacy ...

Biotechnology leader Regeneron Pharmaceuticals is acquiring genetic testing firm 23andMe for $256 million following its bankruptcy filing. The deal excludes 23andMe’s telehealth subsidiary, Lemonaid ...

Regeneron Pharmaceuticals said it will acquire 23andMe's business. What happened to 23andMe? Should you delete your data?

Investors burned by President Trump’s trade fight now have to contend with a spending megabill that risks swelling the ...

Regeneron's win at action means the bankrupt firm's popular DNA-testing service can continue — along with a privacy policy ...

Regeneron Pharmaceutical (REGN) is buying 23andMe’s (MEHCQ) genetics business out of bankruptcy for $256 million, aiming to ...

Regeneron announced a plan to acquire genetic testing firm 23andMe through bankruptcy court, including access to personal genetic data. What to know ...

It will acquire genetic data of more than 15 million customers – raising privacy concerns from individuals who had willingly ...

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection.

Me has found a buyer in biotech company Regeneron Pharmaceuticals. If you want your data removed, here are your options.